Go Pro

XBiotech (XBIT) Institutional Ownership

XBiotech logo
$2.19 +0.01 (+0.46%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$2.18 -0.01 (-0.46%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for XBiotech (NASDAQ:XBIT)

Current
Institutional Ownership
Percentage
55.70%
Number of
Institutional Buyers
(last 12 months)
14
Total
Institutional Inflows
(last 12 months)
$1.54M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.51M
Get XBIT Insider Trade Alerts

Want to know when executives and insiders are buying or selling XBiotech stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

XBIT Institutional Buying and Selling by Quarter

XBiotech Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
9/9/2026 Squarepoint Ops LLC34,757$80K0.0%-15.7%0.114%
8/18/2026 Empowered Funds LLC59,547$137K0.0%N/A0.195%
8/17/2026 Bank of America Corp DE23,789$55K0.0%N/A0.078%
8/13/2026 Connor Clark & Lunn Investment Management Ltd.27,943$64K0.0%N/A0.092%
8/7/2026 BlackRock Inc.321,146$739K0.0%N/A1.053%
8/6/2026 Bank of New York Mellon Corp39,355$91K0.0%N/A0.129%
8/6/2026 GSA Capital Partners LLP30,654$71K0.0%N/A0.101%
5/14/2026 Renaissance Technologies LLC22,438$53K0.0%N/A0.074%
5/7/2026 Dimensional Fund Advisors LP36,053$85K0.0%-28.9%0.118%
5/5/2026 Bank of New York Mellon Corp39,355$92K0.0%-18.8%0.129%
2/18/2026 XTX Topco Ltd21,703$52K0.0%+44.1%0.071%
2/18/2026 Millennium Management LLC135,438$324K0.0%-67.5%0.444%
2/18/2026 Bridgeway Capital Management LLC89,547$214K0.0%+50.4%0.294%
2/17/2026 Persistent Asset Partners Ltd13,565$32K0.0%N/A0.044%
2/13/2026 State Street Corp73,006$174K0.0%+8.5%0.239%
2/12/2026 Jane Street Group LLC69,738$167K0.0%+25.1%0.229%
2/12/2026 Dimensional Fund Advisors LP50,695$121K0.0%-21.2%0.166%
2/10/2026 Goldman Sachs Group Inc.16,831$40K0.0%-32.7%0.055%
11/17/2025 Millennium Management LLC416,344$1.11M0.0%-24.5%1.366%
11/17/2025 Citadel Advisors LLC42,816$114K0.0%+31.8%0.140%
11/17/2025 Bank of America Corp DE47,389$126K0.0%+160.3%0.155%
11/14/2025 Squarepoint Ops LLC62,159$165K0.0%+56.3%0.204%
11/12/2025 Dimensional Fund Advisors LP64,316$171K0.0%-9.4%0.211%
11/7/2025Vanguard Group Inc.819,239$2.18M0.0%-13.3%2.687%
8/15/2025 BNP Paribas Financial Markets20,729$62K0.0%+27.1%0.068%
8/15/2025 Bridgeway Capital Management LLC59,326$176K0.0%-51.8%0.195%
8/15/2025 Bank of America Corp DE18,208$54K0.0%+41.5%0.060%
8/14/2025 Jane Street Group LLC25,322$75K0.0%N/A0.083%
8/14/2025 RBF Capital LLC200,000$594K0.0%N/A0.656%
8/14/2025 Qube Research & Technologies Ltd32,218$96K0.0%N/A0.106%
8/12/2025 XTX Topco Ltd20,408$61K0.0%N/A0.067%
8/12/2025 American Century Companies Inc.25,876$77K0.0%-74.5%0.085%
8/12/2025 JPMorgan Chase & Co.8,881$26K0.0%-70.6%0.029%
8/8/2025 Geode Capital Management LLC220,679$656K0.0%-52.2%0.724%
8/7/2025 Connor Clark & Lunn Investment Management Ltd.48,274$143K0.0%-25.9%0.158%
8/1/2025 Y Intercept Hong Kong Ltd47,885$142K0.0%N/A0.157%
6/27/2025 Goldman Sachs Group Inc.47,182$153K0.0%-12.2%0.155%
5/16/2025Goldman Sachs Group Inc.47,182$153K0.0%-12.2%0.155%
5/14/2025Hsbc Holdings PLC15,984$52K0.0%N/A0.052%
5/13/2025American Century Companies Inc.101,658$329K0.0%-18.2%0.333%
The hidden costs of a hands-off retirement account (Ad)

Contributing to your 401(k) consistently is good financial behavior - but contributing and optimizing are two different things. High fees, heavy company stock concentration, and target-date funds that follow a formula rather than your situation can quietly erode your balance over time. 74% of U.S. millionaires work with a financial advisor - more than double the general population rate. A fiduciary advisor can review your 401(k) for fees, allocation, and alignment with your actual timeline. SmartAsset's free quiz matches nearly 50,000 people each month with vetted fiduciary advisors in their area.tc pixel

Take the free quiz to find a fiduciary advisor near you
5/12/2025Nuveen LLC24,879$81K0.0%N/A0.082%
5/12/2025Connor Clark & Lunn Investment Management Ltd.65,185$211K0.0%-12.1%0.214%
5/9/2025Charles Schwab Investment Management Inc.67,355$218K0.0%+15.3%0.221%
2/17/2025Millennium Management LLC263,522$1.04M0.0%-6.2%0.865%
2/17/2025Deutsche Bank AG30,338$120K0.0%N/A0.100%
2/17/2025Bank of America Corp DE19,888$79K0.0%+42.0%0.065%
2/17/2025BNP Paribas Financial Markets17,368$69K0.0%-56.6%0.057%
2/14/2025Northern Trust Corp211,476$835K0.0%+15.2%0.694%
2/13/2025Barclays PLC30,004$119K0.0%+13.9%0.098%
2/12/2025National Bank of Canada FI25,000$99K0.0%-24.2%0.082%
2/12/2025JPMorgan Chase & Co.14,624$58K0.0%+68.2%0.048%
2/11/2025American Century Companies Inc.124,245$491K0.0%-4.6%0.408%
2/11/2025Virtu Financial LLC14,735$58K0.0%N/A0.048%
2/4/2025Bank of New York Mellon Corp91,060$360K0.0%+7.5%0.299%
1/28/2025Empowered Funds LLC59,589$235K0.0%-4.7%0.196%
11/19/2024Barclays PLC26,343$204K0.0%+247.4%0.086%
11/16/2024Geode Capital Management LLC452,264$3.50M0.0%+5.1%1.484%
11/15/2024Barclays PLC26,343$204K0.0%+247.4%0.086%
11/15/2024Jane Street Group LLC11,141$86K0.0%N/A0.037%
11/15/2024State Street Corp224,595$1.74M0.0%+10.7%0.737%
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC253,770$1.96M0.0%+2.2%0.833%
11/14/2024MetLife Investment Management LLC12,157$94K0.0%N/A0.040%
11/13/2024BNP Paribas Financial Markets40,040$310K0.0%+184.9%0.131%
11/13/2024FMR LLC28,992$224K0.0%+34.4%0.095%
11/12/2024Charles Schwab Investment Management Inc.58,437$452K0.0%+7.9%0.192%
11/8/2024Connor Clark & Lunn Investment Management Ltd.75,715$585K0.0%-2.6%0.249%
11/6/2024Empowered Funds LLC62,551$484K0.0%-9.5%0.205%
8/14/2024Marshall Wace LLP10,573$54K0.0%-80.7%0.035%
8/8/2024American Century Companies Inc.76,460$393K0.0%N/A0.251%
8/1/2024Rhumbline Advisers20,094$103K0.0%+2,568.5%0.066%
7/26/2024Bank of New York Mellon Corp98,314$505K0.0%+102.9%0.323%
5/10/2024Vanguard Group Inc.895,315$7.28M0.0%+1.6%2.940%
5/7/2024Empowered Funds LLC64,277$523K0.0%+7.9%0.211%
2/6/2024National Bank of Canada FI24,347$103K0.0%N/A0.080%
8/7/2023Acadian Asset Management LLC5,966$35K0.0%-75.3%0.020%
7/27/2023Virtu Financial LLC10,410$62K0.0%N/A0.034%
7/27/2023EA Series Trust49,776$296K0.0%N/A0.164%
5/10/2023Connor Clark & Lunn Investment Management Ltd.57,916$200K0.0%-10.9%0.190%
2/10/2023Connor Clark & Lunn Investment Management Ltd.65,026$228K0.0%-4.3%0.214%
11/10/2022Connor Clark & Lunn Investment Management Ltd.67,975$246K0.0%+38.4%0.223%
8/11/2022Trexquant Investment LP30,969$174K0.0%+83.2%0.102%
8/5/2022Connor Clark & Lunn Investment Management Ltd.49,112$277K0.0%+108.1%0.161%


XBIT Institutional Ownership - Frequently Asked Questions

During the previous two years, 36 institutional investors and hedge funds held shares of XBiotech. The most heavily invested institutionals were Vanguard Group Inc. ($2.18M), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ($1.96M), Northern Trust Corp ($835K), BlackRock Inc. ($739K), Geode Capital Management LLC ($656K), RBF Capital LLC ($594K), and Millennium Management LLC ($324K).Learn more on XBiotech's institutional investors.

55.70% of XBiotech's stock is owned by institutional investors. Learn more on XBIT's institutional investor holdings.

Of the 30 institutional investors that purchased XBiotech's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($321.15K), RBF Capital LLC ($200K), Bank of America Corp DE ($64.20K), Empowered Funds LLC ($59.55K), Jane Street Group LLC ($50.43K), Y Intercept Hong Kong Ltd ($47.89K), and Bank of New York Mellon Corp ($45.68K).

Institutional investors have bought a total of 656,652 shares in the last 24 months. This purchase volume represents approximately $1.54M in transactions.

The following institutional investors have sold XBiotech stock in the last 24 months: Millennium Management LLC ($415.91K), Vanguard Group Inc. ($126.17K), Dimensional Fund Advisors LP ($34.91K), Bank of New York Mellon Corp ($9.10K), Goldman Sachs Group Inc. ($8.17K), and Squarepoint Ops LLC ($6.46K).

Institutional investors have sold a total of 600,711 shares in the last 24 months. This volume of shares sold represents approximately $1.51M in transactions.



Institutional ownership data for NASDAQ:XBIT is compiled from quarterly 13F filings submitted to the U.S. Securities and Exchange Commission (SEC), with the most recent received on 9/9/2026. New 13F filings are added each quarter as they're published.
From Our Partners